新種の突然変異は,メドゥロブラストーマの異なるサブグループを標的とする
Giles Robinson1, Matthew Parker, Tanya A Kranenburg
1St Jude Children's Research Hospital, Washington University Pediatric Cancer Genome Project, Memphis, Tennessee 38105, USA.
Nature
|June 23, 2012
まとめ
この研究では,小児期の脳腫瘍である髄芽細胞腫を駆動する新しい遺伝子変異が特定されました. これらの発見は,異なるメドゥロブラストーマサブグループにおける明確な表遺伝的変化を明らかにし,潜在的な治療標的を提供している.
科学分野:
- ゲノミクスゲノミクスとは
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
背景:
- 髄芽細胞腫 (Medulloblastoma) は,4つの異なる分子サブグループを持つ悪性小児脳腫瘍である.
- 髄芽細胞腫の遺伝的要因を理解することは,標的治療の開発に不可欠です.
研究 の 目的:
- そのサブグループ全体でメドゥロブラストーマ発達の原動力となる新しい体的変異を特定する.
- 髄芽細胞腫の病原性における表遺伝子機構の変化の役割を調査する.
主な方法:
- 37の髄芽細胞腫腫瘍の全ゲノム配列解析と正常な血液との一致した.
- さらに56の髄芽細胞腫で136の遺伝子の標的配列を決定した.
- WNTサブグループメドゥロブラストーマのマウス祖先における突然変異のインビボモデリング.
主要な成果:
- 以前は特徴づけられなかった41の遺伝子で再発性突然変異を特定しました.
- 3および4のサブグループにおけるH3K27およびH3K4トリメチル化 (例えば,KDM6A,ZMYM3) のレギュレータを含むサブグループ特有の表遺伝子変化を発見した.
- CTNNB1関連クロマチンリモデレータ (例えば,SMARCA4,CREBBP) がWNTサブグループ腫瘍で発見されました.
- マウスモデルでは,細胞系統 (DDX3X) を維持し,腫瘍発生 (CDH1,PIK3CA) を開始/協力する遺伝子を明らかにした.
結論:
- この研究は,メドゥロブラストーマサブグループの分子病原性に関する重要な洞察を提供します.
- メドゥロブラストーマの新たな遺伝的誘導因子と治療標的を特定し,特に表遺伝的調節因子に焦点を当てた.
関連する概念動画
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

